|
|
.
See Category: Diseases of the musculoskeletal system and connective tissue
ICD-10 (CM) Code and Descriptor
|
M06.9 |
Rheumatoid arthritis, unspecified
|
M069 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 24.53%
|
14.14%
|
12.12%
|
10.62%
|
8.80%
|
7.17%
|
5.66%
|
4.40%
|
3.28%
|
2.47%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for M06.9*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
51,606
|
51,623
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
49,278
|
49,529
|
|
97530
|
THERAPEUTIC ACTIVITIES |
45,129
|
76,595
|
|
97110
|
THERAPEUTIC EXERCISES |
43,448
|
71,180
|
|
80053
|
COMPREHEN METABOLIC PANEL |
41,171
|
41,181
|
|
86140
|
C-REACTIVE PROTEIN |
33,887
|
33,889
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
30,203
|
30,269
|
|
85652
|
RBC SED RATE AUTOMATED |
27,903
|
27,903
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
24,235
|
24,455
|
|
96413
|
CHEMO IV INFUSION 1 HR |
21,063
|
21,064
|
|
J0129
|
ABATACEPT INJECTION |
16,328
|
1,181,459
|
|
97112
|
NEUROMUSCULAR REEDUCATION |
15,199
|
20,708
|
|
97116
|
GAIT TRAINING THERAPY |
14,881
|
18,483
|
|
82565
|
ASSAY OF CREATININE |
14,777
|
14,780
|
|
97535
|
SELF CARE MNGMENT TRAINING |
14,406
|
25,688
|
|
96415
|
CHEMO IV INFUSION ADDL HR |
13,405
|
20,206
|
|
J3262
|
TOCILIZUMAB INJECTION |
11,023
|
3,520,347
|
|
J7050
|
NORMAL SALINE SOLUTION INFUS |
10,899
|
11,615
|
|
84450
|
TRANSFERASE (AST) (SGOT) |
10,272
|
10,272
|
|
J1745
|
INFLIXIMAB NOT BIOSIMIL 10MG |
9,546
|
405,280
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
M06.9 related to the following DRG Codes:
545-547
|
